Protein | Potency Measurements | Inhibition Measurements | Activation Measurements | Drugs |
hypoxia-inducible factor 1 alpha subunit | 6 | 0 | 0 | 6 |
RAR-related orphan receptor gamma | 21 | 0 | 0 | 21 |
GLI family zinc finger 3 | 24 | 0 | 0 | 24 |
AR protein | 24 | 0 | 0 | 24 |
aldehyde dehydrogenase 1 family, member A1 | 17 | 0 | 0 | 17 |
retinoic acid nuclear receptor alpha variant 1 | 21 | 0 | 0 | 21 |
retinoid X nuclear receptor alpha | 18 | 0 | 0 | 18 |
estrogen nuclear receptor alpha | 27 | 0 | 0 | 27 |
peroxisome proliferator-activated receptor delta | 9 | 0 | 0 | 9 |
cytochrome P450, family 19, subfamily A, polypeptide 1, isoform CRA_a | 15 | 0 | 0 | 15 |
activating transcription factor 6 | 10 | 0 | 0 | 10 |
v-jun sarcoma virus 17 oncogene homolog (avian) | 10 | 0 | 0 | 10 |
Histone H2A.x | 4 | 0 | 0 | 4 |
thyroid hormone receptor beta isoform a | 9 | 0 | 0 | 9 |
heat shock protein beta-1 | 7 | 0 | 0 | 7 |
nuclear factor erythroid 2-related factor 2 isoform 1 | 21 | 0 | 0 | 21 |
lamin isoform A-delta10 | 12 | 0 | 0 | 12 |
Voltage-dependent calcium channel gamma-2 subunit | 11 | 0 | 0 | 11 |
Glutamate receptor 2 | 11 | 0 | 0 | 11 |
CAD protein [Includes: Glutamine-dependent carbamoyl-phosphate synthase | 0 | 0 | 0 | 1 |
Dihydroorotate dehydrogenase (quinone), mitochondrial | 0 | 0 | 0 | 1 |
Chain A, TYROSYL-DNA PHOSPHODIESTERASE | 8 | 0 | 0 | 8 |
Chain A, CARBONIC ANHYDRASE II | 0 | 0 | 1 | 1 |
Chain A, CARBONIC ANHYDRASE II | 0 | 0 | 1 | 1 |
Chain A, CARBONIC ANHYDRASE II | 0 | 0 | 1 | 1 |
Chain A, Carbonic Anhydrase Ii | 0 | 0 | 1 | 1 |
Chain A, Carbonic Anhydrase Ii | 0 | 0 | 1 | 1 |
Chain A, Beta-lactamase | 8 | 0 | 0 | 8 |
Chain A, Endochitinase | 0 | 1 | 0 | 1 |
Chain A, Endochitinase | 0 | 1 | 0 | 1 |
Chain A, Endochitinase | 0 | 1 | 0 | 1 |
Chain A, Class Iii Chitinase Chia1 | 0 | 1 | 0 | 1 |
Chain A, Carbonic anhydrase 13 | 0 | 1 | 0 | 1 |
Chain A, Carbonic anhydrase II | 0 | 1 | 0 | 1 |
Chain A, Carbonic anhydrase 2 | 0 | 1 | 0 | 1 |
Chain A, Carbonic anhydrase 2 | 0 | 1 | 0 | 1 |
Chain A, Carbonic anhydrase 2 | 0 | 1 | 0 | 1 |
Chain A, Carbonic anhydrase 2 | 0 | 1 | 0 | 1 |
Chain A, Carbonic anhydrase 2 | 0 | 1 | 0 | 1 |
Chain A, Carbonic anhydrase 2 | 0 | 1 | 0 | 1 |
Chain A, Carbonic anhydrase 2 | 0 | 1 | 0 | 1 |
Chain A, Carbonic anhydrase 2 | 0 | 1 | 0 | 1 |
Chain A, Carbonic anhydrase 2 | 0 | 1 | 0 | 1 |
Chain A, Carbonic anhydrase | 0 | 1 | 0 | 1 |
Chain B, Carbonic anhydrase | 0 | 1 | 0 | 1 |
Chain A, Carbonic anhydrase 2 | 0 | 1 | 0 | 1 |
Carbonic anhydrase | 0 | 0 | 0 | 1 |
Carbonic anhydrase | 0 | 1 | 0 | 1 |
thioredoxin reductase | 13 | 0 | 0 | 13 |
GALC protein | 3 | 0 | 0 | 3 |
nuclear receptor subfamily 1, group I, member 3 | 18 | 0 | 0 | 18 |
cytochrome P450 family 3 subfamily A polypeptide 4 | 12 | 0 | 0 | 12 |
glucocorticoid receptor [Homo sapiens] | 18 | 0 | 0 | 18 |
estrogen-related nuclear receptor alpha | 23 | 0 | 0 | 23 |
Carbonic anhydrase | 0 | 1 | 0 | 1 |
Carbonic anhydrase | 0 | 1 | 0 | 1 |
arylsulfatase A | 8 | 0 | 0 | 8 |
Carbonic anhydrase | 0 | 1 | 0 | 1 |
euchromatic histone-lysine N-methyltransferase 2 | 21 | 0 | 0 | 21 |
Bloom syndrome protein isoform 1 | 9 | 0 | 0 | 9 |
geminin | 18 | 0 | 0 | 18 |
peripheral myelin protein 22 | 7 | 0 | 0 | 7 |
survival motor neuron protein isoform d | 5 | 0 | 0 | 5 |
muscleblind-like protein 1 isoform 1 | 2 | 0 | 0 | 2 |
Gamma-aminobutyric acid receptor subunit pi | 7 | 6 | 2 | 15 |
ATP-binding cassette sub-family C member 3 | 0 | 18 | 0 | 18 |
Multidrug resistance-associated protein 4 | 0 | 18 | 0 | 18 |
Carbonic anhydrase | 0 | 1 | 0 | 1 |
Solute carrier family 22 member 6 | 0 | 4 | 0 | 4 |
Carbonic anhydrase 12 | 0 | 3 | 1 | 6 |
Prolyl endopeptidase | 0 | 1 | 0 | 1 |
Carbonic anhydrase-related protein 11 | 0 | 1 | 0 | 2 |
Bile salt export pump | 0 | 25 | 0 | 25 |
Glycogen phosphorylase, muscle form | 0 | 2 | 0 | 2 |
Renin | 0 | 3 | 0 | 3 |
Carbonic anhydrase 1 | 0 | 8 | 1 | 14 |
Carbonic anhydrase 2 | 0 | 8 | 1 | 13 |
Carbonic anhydrase 2 | 0 | 2 | 0 | 2 |
Cytochrome P450 1A2 | 0 | 4 | 1 | 6 |
Carbonic anhydrase 3 | 0 | 3 | 1 | 6 |
Cathepsin B | 0 | 1 | 0 | 1 |
Cytochrome P450 3A4 | 0 | 5 | 1 | 7 |
Steryl-sulfatase | 0 | 1 | 0 | 1 |
5-hydroxytryptamine receptor 2C | 0 | 1 | 0 | 1 |
Polyunsaturated fatty acid 5-lipoxygenase | 0 | 1 | 0 | 1 |
Cytochrome P450 2C8 | 0 | 3 | 0 | 3 |
Cytochrome P450 2D6 | 0 | 6 | 1 | 7 |
Cytochrome P450 2A6 | 0 | 2 | 0 | 2 |
Cytochrome P450 2C9 | 0 | 3 | 1 | 4 |
5-hydroxytryptamine receptor 2A | 0 | 1 | 0 | 1 |
Androgen receptor | 0 | 5 | 0 | 5 |
Gamma-aminobutyric acid receptor subunit beta-1 | 7 | 6 | 2 | 15 |
Translocator protein | 0 | 1 | 0 | 1 |
Gamma-aminobutyric acid receptor subunit delta | 7 | 6 | 2 | 15 |
Gamma-aminobutyric acid receptor subunit gamma-2 | 7 | 6 | 2 | 15 |
Gamma-aminobutyric acid receptor subunit alpha-5 | 7 | 6 | 2 | 15 |
Gamma-aminobutyric acid receptor subunit alpha-3 | 7 | 6 | 2 | 15 |
Cannabinoid receptor 1 | 0 | 1 | 0 | 1 |
Arachidonate 5-lipoxygenase-activating protein | 0 | 1 | 0 | 1 |
Cytochrome P450 2B6 | 0 | 1 | 0 | 1 |
Carbonic anhydrase 4 | 0 | 3 | 1 | 5 |
Carbonic anhydrase 6 | 0 | 3 | 1 | 5 |
Gamma-aminobutyric acid receptor subunit gamma-1 | 7 | 6 | 2 | 15 |
Gamma-aminobutyric acid receptor subunit alpha-2 | 7 | 6 | 2 | 15 |
Carbonic anhydrase 5A, mitochondrial | 0 | 1 | 0 | 1 |
Adenosine receptor A1 | 0 | 4 | 0 | 5 |
Serum paraoxonase/arylesterase 1 | 0 | 1 | 0 | 1 |
Dipeptidyl peptidase 4 | 0 | 0 | 0 | 1 |
Gamma-aminobutyric acid receptor subunit alpha-4 | 7 | 6 | 2 | 15 |
Gamma-aminobutyric acid receptor subunit gamma-3 | 7 | 6 | 2 | 15 |
Endochitinase | 0 | 1 | 0 | 1 |
Gamma-aminobutyric acid receptor subunit alpha-6 | 7 | 6 | 2 | 15 |
Adenosine receptor A2a | 0 | 4 | 0 | 6 |
5-hydroxytryptamine receptor 2B | 0 | 1 | 0 | 1 |
Sodium-dependent serotonin transporter | 0 | 3 | 1 | 4 |
Delta-type opioid receptor | 0 | 1 | 0 | 1 |
Cytochrome P450 2C19 | 0 | 4 | 1 | 5 |
Delta-type opioid receptor | 0 | 1 | 0 | 1 |
Mu-type opioid receptor | 0 | 1 | 0 | 1 |
Carbonic anhydrase 5A, mitochondrial | 0 | 3 | 1 | 6 |
Carbonic anhydrase | 0 | 1 | 0 | 1 |
Kappa-type opioid receptor | 0 | 1 | 0 | 1 |
Carbonic anhydrase 7 | 0 | 3 | 1 | 5 |
Carbonic anhydrase | 0 | 1 | 0 | 1 |
D(1A) dopamine receptor | 1 | 1 | 0 | 2 |
Corticosteroid 11-beta-dehydrogenase isozyme 1 | 0 | 1 | 0 | 1 |
Carbonic anhydrase | 0 | 1 | 0 | 1 |
D(2) dopamine receptor | 0 | 1 | 0 | 1 |
Gamma-aminobutyric acid receptor subunit alpha-1 | 7 | 7 | 2 | 16 |
Gamma-aminobutyric acid receptor subunit beta-3 | 7 | 6 | 2 | 15 |
Gamma-aminobutyric acid receptor subunit beta-2 | 7 | 6 | 2 | 15 |
Cholinesterase | 0 | 2 | 0 | 2 |
Carbonic anhydrase | 0 | 1 | 0 | 1 |
Mu-type opioid receptor | 0 | 1 | 0 | 1 |
Fatty-acid amide hydrolase 1 | 0 | 2 | 0 | 2 |
Beta-carbonic anhydrase 1 | 0 | 1 | 0 | 1 |
Carbonic anhydrase 2 | 0 | 1 | 0 | 1 |
Glutamate receptor ionotropic, NMDA 2B | 0 | 3 | 0 | 3 |
Squalene synthase | 0 | 1 | 0 | 1 |
Neuronal acetylcholine receptor subunit alpha-7 | 0 | 2 | 0 | 2 |
Carbonic anhydrase 9 | 0 | 3 | 1 | 6 |
Carbonic anhydrase | 0 | 2 | 0 | 2 |
Carbonic anhydrase, alpha family | 0 | 1 | 0 | 1 |
Carbonic anhydrase | 0 | 1 | 0 | 1 |
Carbonic anhydrase 3 | 0 | 1 | 0 | 1 |
Carbonic anhydrase | 0 | 1 | 0 | 2 |
Carbonic anhydrase | 0 | 1 | 0 | 2 |
Carbonic anhydrase | 0 | 1 | 0 | 1 |
Sigma intracellular receptor 2 | 0 | 1 | 0 | 1 |
Delta carbonic anhydrase | 0 | 1 | 0 | 1 |
Sigma non-opioid intracellular receptor 1 | 0 | 1 | 0 | 1 |
Renin | 0 | 1 | 0 | 1 |
Carbonic anhydrase | 0 | 1 | 0 | 1 |
Endochitinase A1 | 0 | 1 | 0 | 1 |
Multidrug resistance-associated protein 1 | 0 | 1 | 0 | 1 |
Carbonic anhydrase 13 | 0 | 2 | 1 | 4 |
GABA theta subunit | 7 | 6 | 2 | 15 |
Canalicular multispecific organic anion transporter 1 | 0 | 18 | 0 | 18 |
Carbonic anhydrase 4 | 0 | 2 | 0 | 3 |
Carbonic anhydrase 15 | 0 | 2 | 0 | 3 |
Acidic mammalian chitinase | 0 | 1 | 0 | 1 |
Carbonic anhydrase 13 | 0 | 3 | 0 | 4 |
Carbonic anhydrase 7 | 0 | 1 | 0 | 1 |
Gamma-aminobutyric acid receptor subunit epsilon | 7 | 6 | 2 | 15 |
Carbonic anhydrase | 0 | 1 | 0 | 1 |
Carbonic anhydrase 14 | 0 | 3 | 1 | 6 |
Carbonic anhydrase | 0 | 1 | 0 | 1 |
Carbonic anhydrase 2, isoform A | 0 | 1 | 0 | 1 |
Carbonic anhydrase 5B, mitochondrial | 0 | 3 | 1 | 6 |
Chain A, MAJOR APURINIC/APYRIMIDINIC ENDONUCLEASE | 12 | 0 | 0 | 12 |
Alanine racemase, biosynthetic | 0 | 0 | 0 | 1 |
5-hydroxytryptamine receptor 1D | 0 | 0 | 0 | 1 |
Glutamate receptor ionotropic, NMDA 1 | 0 | 3 | 0 | 3 |
Proton-coupled amino acid transporter 1 | 0 | 1 | 0 | 1 |
Adenosine deaminase | 0 | 0 | 0 | 1 |
ATAD5 protein, partial | 7 | 0 | 0 | 7 |
Lysyl oxidase homolog 2 | 0 | 1 | 0 | 1 |
Protein-lysine 6-oxidase | 0 | 1 | 0 | 1 |
Protein-lysine 6-oxidase | 0 | 1 | 0 | 1 |
Lysyl oxidase homolog 2 | 0 | 1 | 0 | 1 |
Lysyl oxidase homolog 3 | 0 | 1 | 0 | 1 |
Lysyl oxidase homolog 4 | 0 | 1 | 0 | 1 |
Lysyl oxidase homolog 2 | 0 | 1 | 0 | 1 |
TDP1 protein | 20 | 0 | 0 | 20 |
Microtubule-associated protein tau | 6 | 0 | 0 | 6 |
D(1A) dopamine receptor | 4 | 0 | 0 | 4 |
neuropeptide S receptor isoform A | 2 | 0 | 0 | 2 |
Chain E, LYSINE, ARGININE, ORNITHINE-BINDING PROTEIN | 0 | 0 | 1 | 1 |
Chain E, LYSINE, ARGININE, ORNITHINE-BINDING PROTEIN | 0 | 0 | 1 | 1 |
Chain E, LYSINE, ARGININE, ORNITHINE-BINDING PROTEIN | 0 | 0 | 1 | 1 |
phosphopantetheinyl transferase | 10 | 0 | 0 | 10 |
NFKB1 protein, partial | 1 | 0 | 0 | 1 |
GLS protein | 9 | 0 | 0 | 9 |
thyroid stimulating hormone receptor | 8 | 0 | 0 | 8 |
alpha-galactosidase | 2 | 0 | 0 | 2 |
cytochrome P450 2C19 precursor | 4 | 0 | 0 | 4 |
chromobox protein homolog 1 | 10 | 0 | 0 | 10 |
flap endonuclease 1 | 5 | 0 | 0 | 5 |
DNA polymerase iota isoform a (long) | 9 | 0 | 0 | 9 |
muscarinic acetylcholine receptor M1 | 7 | 0 | 0 | 7 |
lethal factor (plasmid) | 4 | 0 | 0 | 4 |
Nitric oxide synthase, endothelial | 0 | 0 | 0 | 2 |
Nitric oxide synthase, brain | 0 | 0 | 0 | 1 |
Nitric oxide synthase, brain | 0 | 0 | 0 | 1 |
Nitric oxide synthase, inducible | 0 | 0 | 0 | 1 |
Nitric oxide synthase, inducible | 0 | 0 | 1 | 3 |
Cationic amino acid transporter 3 | 0 | 2 | 0 | 2 |
ATP-dependent phosphofructokinase | 6 | 0 | 0 | 6 |
Chain A, Phospholipase A2 isoform 3 | 0 | 0 | 1 | 1 |
Chain A, HADH2 protein | 4 | 0 | 0 | 4 |
Chain B, HADH2 protein | 4 | 0 | 0 | 4 |
Chain A, 2-oxoglutarate Oxygenase | 8 | 0 | 0 | 8 |
GTP-binding protein (rab7) | 0 | 0 | 1 | 1 |
ras protein, partial | 0 | 0 | 1 | 1 |
interleukin 8 | 4 | 0 | 0 | 4 |
hypothetical protein, conserved | 1 | 0 | 0 | 1 |
EWS/FLI fusion protein | 7 | 0 | 0 | 7 |
cytochrome P450 2D6 | 8 | 0 | 0 | 8 |
glucocerebrosidase | 1 | 0 | 0 | 1 |
Rac1 protein | 0 | 0 | 1 | 1 |
IDH1 | 6 | 0 | 0 | 6 |
cell division cycle 42 (GTP binding protein, 25kDa), partial | 0 | 0 | 1 | 1 |
15-hydroxyprostaglandin dehydrogenase [NAD(+)] isoform 1 | 5 | 0 | 0 | 5 |
DNA polymerase kappa isoform 1 | 3 | 0 | 0 | 3 |
Prostaglandin-H2 D-isomerase | 0 | 1 | 0 | 1 |
Prostaglandin G/H synthase 1 | 0 | 1 | 0 | 1 |
Prostaglandin G/H synthase 2 | 0 | 1 | 0 | 1 |
Epidermal growth factor receptor | 0 | 1 | 0 | 1 |
Fatty acid-binding protein, liver | 0 | 1 | 0 | 1 |
Integrin beta-3 | 3 | 1 | 0 | 4 |
Myeloperoxidase | 0 | 3 | 0 | 3 |
Prostaglandin G/H synthase 1 | 0 | 2 | 0 | 2 |
Seed linoleate 13S-lipoxygenase-1 | 0 | 1 | 0 | 1 |
Integrin alpha-IIb | 3 | 1 | 0 | 4 |
Glutathione hydrolase 1 proenzyme | 0 | 1 | 0 | 1 |
Prostaglandin G/H synthase 1 | 0 | 5 | 0 | 5 |
Substance-P receptor | 0 | 1 | 0 | 1 |
Prostaglandin G/H synthase 2 | 0 | 3 | 0 | 3 |
Urotensin-2 receptor | 0 | 1 | 0 | 1 |
4-aminobutyrate aminotransferase, mitochondrial | 0 | 1 | 0 | 1 |
Nuclear receptor ROR-gamma | 5 | 2 | 2 | 9 |
Ras-related protein Rab-2A | 0 | 0 | 1 | 1 |
Prostaglandin G/H synthase 2 | 0 | 2 | 0 | 2 |
Rho-associated protein kinase 2 | 0 | 1 | 0 | 1 |
Nicotinate phosphoribosyltransferase | 0 | 2 | 0 | 2 |
Solute carrier family 22 member 20 | 0 | 2 | 0 | 2 |
Solute carrier family 22 member 6 | 0 | 2 | 0 | 2 |
Sigma non-opioid intracellular receptor 1 | 0 | 4 | 1 | 5 |
Sigma non-opioid intracellular receptor 1 | 0 | 0 | 1 | 1 |
pregnane X nuclear receptor | 16 | 0 | 0 | 16 |
cystic fibrosis transmembrane conductance regulator | 0 | 1 | 0 | 1 |
DNA polymerase beta | 3 | 0 | 0 | 3 |
short transient receptor potential channel 6 isoform 1 | 0 | 0 | 1 | 1 |
Solute carrier family 22 member 1 | 0 | 5 | 0 | 6 |
5-hydroxytryptamine receptor 4 | 0 | 6 | 0 | 6 |
Muscarinic acetylcholine receptor M2 | 0 | 7 | 2 | 12 |
Muscarinic acetylcholine receptor M4 | 0 | 5 | 1 | 8 |
Muscarinic acetylcholine receptor M1 | 0 | 2 | 1 | 5 |
Muscarinic acetylcholine receptor M3 | 0 | 2 | 1 | 5 |
Muscarinic acetylcholine receptor M4 | 0 | 2 | 1 | 5 |
Muscarinic acetylcholine receptor M5 | 0 | 2 | 1 | 5 |
Muscarinic acetylcholine receptor M5 | 0 | 5 | 1 | 8 |
Muscarinic acetylcholine receptor M2 | 0 | 2 | 1 | 6 |
Muscarinic acetylcholine receptor M1 | 0 | 6 | 2 | 11 |
Muscarinic acetylcholine receptor M1 | 0 | 0 | 0 | 1 |
Muscarinic acetylcholine receptor M3 | 0 | 7 | 2 | 11 |
Alpha-1D adrenergic receptor | 0 | 3 | 1 | 5 |
5-hydroxytryptamine receptor 2C | 0 | 6 | 1 | 7 |
Muscarinic acetylcholine receptor M4 | 0 | 1 | 0 | 1 |
Histamine H2 receptor | 2 | 0 | 0 | 3 |
5-hydroxytryptamine receptor 7 | 0 | 3 | 0 | 3 |
Reverse transcriptase/RNaseH | 0 | 0 | 0 | 1 |
Muscarinic acetylcholine receptor | 0 | 1 | 1 | 3 |
Chain A, Glycogen Phosphorylase | 0 | 1 | 0 | 1 |
Chain A, Glycogen phosphorylase, liver form | 0 | 0 | 1 | 1 |
Chain A, glycogen phosphorylase, liver form | 0 | 0 | 1 | 1 |
Chain A, Glycogen phosphorylase, liver form | 0 | 0 | 1 | 1 |
Chain A, Glycogen phosphorylase, liver form | 0 | 0 | 1 | 1 |
Chain A, Chitinase | 0 | 1 | 0 | 1 |
farnesoid X nuclear receptor | 11 | 0 | 0 | 11 |
thyroid stimulating hormone receptor | 12 | 0 | 0 | 12 |
atrial natriuretic peptide receptor 1 precursor | 1 | 0 | 0 | 1 |
thyroid hormone receptor beta isoform 2 | 14 | 0 | 0 | 14 |
nuclear receptor ROR-gamma isoform 1 | 8 | 0 | 0 | 8 |
Potassium channel subfamily K member 2 | 0 | 2 | 1 | 3 |
Cholinesterase | 0 | 1 | 0 | 1 |
Glycogen phosphorylase, liver form | 0 | 1 | 0 | 1 |
Glycogen phosphorylase, muscle form | 0 | 1 | 0 | 1 |
Replicase polyprotein 1ab | 0 | 1 | 0 | 1 |
Adenosine receptor A3 | 0 | 6 | 1 | 7 |
Replicase polyprotein 1ab | 0 | 2 | 0 | 2 |
Amine oxidase [flavin-containing] A | 0 | 1 | 0 | 1 |
Acetylcholinesterase | 0 | 4 | 0 | 4 |
Amine oxidase [flavin-containing] B | 0 | 2 | 0 | 2 |
cAMP-specific 3',5'-cyclic phosphodiesterase 4A | 0 | 2 | 0 | 2 |
Adenosine receptor A3 | 0 | 1 | 0 | 1 |
Adenosine receptor A2a | 0 | 3 | 2 | 6 |
Adenosine receptor A2b | 0 | 1 | 0 | 2 |
Adenosine receptor A2b | 0 | 2 | 0 | 3 |
Adenosine receptor A1 | 0 | 1 | 1 | 4 |
Vasopressin V2 receptor | 0 | 0 | 0 | 1 |
Serine/threonine-protein kinase mTOR | 0 | 1 | 0 | 1 |
Adenosine receptor A2a | 0 | 1 | 0 | 1 |
Adenosine receptor A1 | 0 | 1 | 0 | 1 |
Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform | 0 | 1 | 0 | 1 |
DNA-dependent protein kinase catalytic subunit | 0 | 1 | 0 | 1 |
Calcium/calmodulin-dependent 3',5'-cyclic nucleotide phosphodiesterase 1B | 0 | 1 | 0 | 1 |
Adenylate cyclase type 1 | 0 | 0 | 0 | 1 |
Chitotriosidase-1 | 0 | 1 | 0 | 1 |
Serine-protein kinase ATM | 0 | 1 | 0 | 1 |
Serine/threonine-protein kinase ATR | 0 | 1 | 0 | 1 |
Adenosine receptor A2b | 0 | 1 | 0 | 2 |
Calcium/calmodulin-dependent 3',5'-cyclic nucleotide phosphodiesterase 1C | 0 | 1 | 0 | 1 |
Palmitoleoyl-protein carboxylesterase NOTUM | 0 | 1 | 2 | 3 |
Endochitinase B1 | 0 | 1 | 0 | 1 |
Phosphodiesterase | 0 | 1 | 0 | 1 |
Broad substrate specificity ATP-binding cassette transporter ABCG2 | 0 | 1 | 0 | 1 |
Guanine deaminase | 0 | 1 | 0 | 1 |
Alpha-1B adrenergic receptor | 0 | 0 | 1 | 1 |
cytochrome P450 2D6 isoform 1 | 3 | 0 | 0 | 3 |
cellular tumor antigen p53 isoform a | 4 | 0 | 0 | 4 |
cytochrome P450 2C9 precursor | 1 | 0 | 0 | 1 |
cytochrome P450 3A4 isoform 1 | 7 | 0 | 0 | 7 |
Alpha-2A adrenergic receptor | 0 | 2 | 3 | 6 |
Alpha-1B adrenergic receptor | 0 | 6 | 1 | 7 |
Alpha-1A adrenergic receptor | 0 | 1 | 1 | 2 |
Alpha-2C adrenergic receptor | 0 | 2 | 3 | 6 |
Alpha-2B adrenergic receptor | 0 | 2 | 1 | 3 |
Alpha-2C adrenergic receptor | 0 | 2 | 1 | 3 |
Alpha-2A adrenergic receptor | 0 | 2 | 1 | 3 |
Alpha-1D adrenergic receptor | 0 | 3 | 1 | 4 |
Alpha-1A adrenergic receptor | 0 | 6 | 1 | 7 |
Chain A, ATP-DEPENDENT DNA HELICASE Q1 | 2 | 0 | 0 | 2 |
Chain A, Cruzipain | 6 | 0 | 0 | 6 |
PAX8 | 0 | 0 | 0 | 1 |
SMAD family member 2 | 6 | 0 | 0 | 6 |
PPM1D protein | 1 | 0 | 0 | 1 |
SMAD family member 3 | 6 | 0 | 0 | 6 |
STAT3, partial | 0 | 1 | 0 | 1 |
thioredoxin glutathione reductase | 4 | 0 | 0 | 4 |
Smad3 | 2 | 0 | 0 | 2 |
estrogen receptor 2 (ER beta) | 10 | 0 | 0 | 10 |
progesterone receptor | 13 | 0 | 0 | 13 |
regulator of G-protein signaling 4 | 5 | 0 | 0 | 5 |
67.9K protein | 4 | 0 | 0 | 4 |
peroxisome proliferator activated receptor gamma | 14 | 0 | 0 | 14 |
vitamin D (1,25- dihydroxyvitamin D3) receptor | 14 | 0 | 0 | 14 |
nuclear factor of kappa light polypeptide gene enhancer in B-cells 1 (p105), isoform CRA_a | 7 | 0 | 0 | 7 |
NPC intracellular cholesterol transporter 1 precursor | 2 | 0 | 0 | 2 |
tumor necrosis factor | 1 | 0 | 0 | 1 |
nuclear factor erythroid 2-related factor 2 isoform 2 | 6 | 0 | 0 | 6 |
parathyroid hormone/parathyroid hormone-related peptide receptor precursor | 4 | 0 | 0 | 4 |
ras-related protein Rab-9A | 2 | 0 | 0 | 2 |
signal transducer and activator of transcription 1-alpha/beta isoform alpha | 0 | 1 | 0 | 1 |
Solute carrier organic anion transporter family member 1A4 | 0 | 2 | 0 | 3 |
Interferon beta | 9 | 0 | 0 | 9 |
Cellular tumor antigen p53 | 16 | 0 | 0 | 16 |
Sodium/potassium-transporting ATPase subunit alpha-1 | 0 | 2 | 0 | 2 |
Sodium/potassium-transporting ATPase subunit beta-1 | 0 | 2 | 0 | 2 |
Sodium/potassium-transporting ATPase subunit alpha-2 | 0 | 1 | 0 | 1 |
Sodium/potassium-transporting ATPase subunit alpha-3 | 0 | 1 | 0 | 1 |
ATP-dependent translocase ABCB1 | 0 | 1 | 0 | 1 |
Sodium/potassium-transporting ATPase subunit beta-1 | 0 | 1 | 0 | 1 |
ATP-dependent translocase ABCB1 | 0 | 6 | 0 | 8 |
Sodium/potassium-transporting ATPase subunit alpha-3 | 0 | 1 | 0 | 1 |
Sodium/potassium-transporting ATPase subunit beta-2 | 0 | 1 | 0 | 1 |
ATP-dependent translocase ABCB1 | 0 | 1 | 0 | 1 |
Sodium/potassium-transporting ATPase subunit alpha-2 | 0 | 2 | 0 | 2 |
Sodium/potassium-transporting ATPase subunit alpha-1 | 0 | 1 | 0 | 1 |
Sodium/potassium-transporting ATPase subunit beta-3 | 0 | 1 | 0 | 1 |
Sodium/potassium-transporting ATPase subunit gamma | 0 | 1 | 0 | 1 |
Sodium/potassium-transporting ATPase subunit alpha-4 | 0 | 1 | 0 | 1 |
Sodium/potassium-transporting ATPase subunit alpha-4 | 0 | 1 | 0 | 1 |
Solute carrier organic anion transporter family member 4C1 | 0 | 0 | 0 | 1 |
Solute carrier organic anion transporter family member 4C1 | 0 | 0 | 0 | 1 |
ATPase family AAA domain-containing protein 5 | 6 | 0 | 0 | 6 |
Ataxin-2 | 7 | 0 | 0 | 7 |
Solute carrier organic anion transporter family member 1A4 | 0 | 0 | 0 | 1 |
Solute carrier organic anion transporter family member 1B3 | 0 | 1 | 0 | 1 |
Solute carrier organic anion transporter family member 1B1 | 0 | 1 | 0 | 1 |
Endothelin-1 receptor | 0 | 2 | 1 | 3 |
USP1 protein, partial | 5 | 0 | 0 | 5 |
G | 8 | 0 | 0 | 8 |
aryl hydrocarbon receptor | 8 | 0 | 0 | 8 |
HLA class I histocompatibility antigen, B alpha chain | 8 | 0 | 0 | 8 |
Inositol hexakisphosphate kinase 1 | 8 | 0 | 0 | 8 |
cytochrome P450 2C9, partial | 8 | 0 | 0 | 8 |
endonuclease IV | 1 | 0 | 0 | 1 |
Gamma-aminobutyric acid receptor subunit pi | 0 | 2 | 0 | 2 |
Gamma-aminobutyric acid receptor subunit delta | 0 | 2 | 0 | 2 |
Bile salt export pump | 0 | 6 | 0 | 6 |
Gamma-aminobutyric acid receptor subunit alpha-1 | 0 | 2 | 0 | 3 |
Gamma-aminobutyric acid receptor subunit beta-1 | 0 | 2 | 0 | 3 |
Neuronal acetylcholine receptor subunit alpha-4 | 1 | 1 | 0 | 2 |
Gamma-aminobutyric acid receptor subunit alpha-2 | 0 | 2 | 0 | 3 |
Gamma-aminobutyric acid receptor subunit alpha-3 | 0 | 2 | 0 | 3 |
Neuronal acetylcholine receptor subunit beta-2 | 1 | 1 | 0 | 2 |
Gamma-aminobutyric acid receptor subunit alpha-1 | 0 | 4 | 4 | 8 |
Gamma-aminobutyric acid receptor subunit beta-1 | 0 | 2 | 1 | 3 |
Gamma-aminobutyric acid receptor subunit gamma-2 | 0 | 4 | 3 | 7 |
5-hydroxytryptamine receptor 1A | 0 | 4 | 1 | 6 |
Gamma-aminobutyric acid receptor subunit alpha-4 | 0 | 2 | 0 | 3 |
Gamma-aminobutyric acid receptor subunit gamma-2 | 0 | 2 | 0 | 3 |
Gamma-aminobutyric acid receptor subunit beta-3 | 0 | 4 | 2 | 6 |
Gamma-aminobutyric acid receptor subunit alpha-5 | 0 | 3 | 3 | 6 |
Gamma-aminobutyric acid receptor subunit alpha-3 | 0 | 3 | 2 | 5 |
Gamma-aminobutyric acid receptor subunit alpha-2 | 0 | 3 | 1 | 4 |
Gamma-aminobutyric acid receptor subunit beta-2 | 0 | 3 | 2 | 5 |
Gamma-aminobutyric acid receptor subunit alpha-4 | 0 | 2 | 1 | 3 |
Gamma-aminobutyric acid receptor subunit epsilon | 0 | 2 | 0 | 2 |
TAR DNA-binding protein 43 | 3 | 0 | 0 | 3 |
Gamma-aminobutyric acid receptor subunit alpha-6 | 0 | 3 | 1 | 4 |
Gamma-aminobutyric acid receptor subunit gamma-1 | 0 | 2 | 0 | 2 |
Gamma-aminobutyric acid receptor subunit gamma-3 | 0 | 2 | 0 | 2 |
Gamma-aminobutyric acid receptor subunit theta | 0 | 2 | 0 | 2 |
Translocator protein | 0 | 1 | 0 | 1 |
Cholecystokinin receptor type A | 0 | 1 | 0 | 1 |
Gastrin/cholecystokinin type B receptor | 0 | 1 | 0 | 1 |
Luciferase | 6 | 0 | 0 | 6 |
vitamin D3 receptor isoform VDRA | 8 | 0 | 0 | 8 |
Albumin | 0 | 2 | 2 | 4 |
Voltage-dependent L-type calcium channel subunit alpha-1C | 0 | 4 | 0 | 4 |
acetylcholinesterase | 4 | 0 | 0 | 4 |
histone deacetylase 9 isoform 3 | 1 | 0 | 0 | 1 |
Neuronal acetylcholine receptor subunit beta-2 | 0 | 1 | 0 | 1 |
Neuronal acetylcholine receptor subunit alpha-7 | 0 | 1 | 0 | 1 |
bromodomain adjacent to zinc finger domain 2B | 3 | 0 | 0 | 3 |
3-oxoacyl-[acyl-carrier-protein] synthase 3 | 0 | 1 | 0 | 1 |
potassium voltage-gated channel subfamily H member 2 isoform d | 4 | 0 | 0 | 4 |
histone acetyltransferase KAT2A isoform 1 | 5 | 0 | 0 | 5 |
N-glycosylase/DNA lyase | 0 | 1 | 0 | 1 |
Polyphenol oxidase 2 | 0 | 2 | 0 | 3 |
Formamidopyrimidine-DNA glycosylase | 0 | 1 | 0 | 1 |
DNA gyrase subunit A | 0 | 1 | 0 | 1 |
DNA gyrase subunit B | 0 | 1 | 0 | 1 |
Macrophage migration inhibitory factor | 0 | 1 | 0 | 1 |
Endonuclease III-like protein 1 | 0 | 1 | 0 | 1 |
DNA gyrase subunit B | 0 | 1 | 0 | 1 |
DNA gyrase subunit A | 0 | 1 | 0 | 1 |
Enoyl-[acyl-carrier-protein] reductase [NADH] | 0 | 1 | 0 | 3 |
Pantothenate synthetase | 0 | 1 | 0 | 1 |
Isocitrate lyase | 0 | 1 | 0 | 1 |
Putative FAD-containing monooxygenase MymA | 0 | 1 | 0 | 1 |
Dihydrofolate reductase | 0 | 1 | 0 | 1 |
Endonuclease 8-like 1 | 0 | 1 | 0 | 1 |
Chain A, Ferritin light chain | 4 | 0 | 0 | 4 |
Parkin | 4 | 0 | 0 | 4 |
Caspase-7 | 2 | 0 | 0 | 2 |
peripheral myelin protein 22 isoform 1 | 1 | 0 | 0 | 1 |
caspase-3 | 2 | 0 | 0 | 2 |
serine/threonine-protein kinase mTOR isoform 1 | 2 | 0 | 0 | 2 |
serine/threonine-protein kinase PLK1 | 1 | 0 | 0 | 1 |
peptidyl-prolyl cis-trans isomerase NIMA-interacting 1 | 2 | 0 | 0 | 2 |
DNA polymerase eta isoform 1 | 1 | 0 | 0 | 1 |
Ornithine decarboxylase | 0 | 0 | 0 | 2 |
Retinoic acid receptor alpha | 0 | 2 | 2 | 4 |
Alpha-2B adrenergic receptor | 0 | 2 | 1 | 4 |
Retinoic acid receptor gamma | 0 | 2 | 2 | 4 |
Retinoic acid receptor beta | 0 | 2 | 2 | 4 |
Cellular retinoic acid-binding protein 2 | 0 | 0 | 2 | 2 |
Mitogen-activated protein kinase 1 | 0 | 2 | 0 | 2 |
Retinoic acid receptor RXR-alpha | 0 | 2 | 2 | 4 |
Retinoic acid receptor RXR-beta | 0 | 2 | 2 | 4 |
Retinoic acid receptor RXR-gamma | 0 | 2 | 2 | 4 |
Cellular retinoic acid-binding protein 1 | 0 | 2 | 0 | 3 |
5-hydroxytryptamine receptor 2B | 0 | 8 | 1 | 9 |
Cellular retinoic acid-binding protein 1 | 0 | 0 | 2 | 2 |
Mitogen-activated protein kinase 14 | 0 | 1 | 0 | 1 |
Rap guanine nucleotide exchange factor 4 | 1 | 0 | 0 | 1 |
Olfactory receptor 51E2 | 0 | 1 | 0 | 1 |
Chymotrypsinogen A | 0 | 1 | 0 | 1 |
Glutamate receptor ionotropic, NMDA 2D | 0 | 1 | 0 | 1 |
Acetylcholinesterase | 0 | 1 | 0 | 1 |
Glutamate receptor ionotropic, NMDA 3B | 0 | 1 | 0 | 1 |
Rap guanine nucleotide exchange factor 3 | 3 | 0 | 0 | 3 |
Sodium channel protein type 4 subunit alpha | 0 | 2 | 0 | 2 |
Glutamate receptor ionotropic, NMDA 2A | 0 | 2 | 0 | 2 |
Glutamate receptor ionotropic, NMDA 2C | 0 | 2 | 0 | 2 |
Glutamate receptor ionotropic, NMDA 1 | 0 | 2 | 0 | 2 |
Glutamate receptor ionotropic, NMDA 2A | 0 | 2 | 0 | 2 |
Glutamate receptor ionotropic, NMDA 2B | 0 | 2 | 0 | 2 |
Glutamate receptor ionotropic, NMDA 2C | 0 | 1 | 0 | 1 |
Glutamate receptor ionotropic, NMDA 2D | 0 | 2 | 0 | 2 |
Glutamate receptor ionotropic, NMDA 3A | 0 | 1 | 0 | 1 |
Glutamate receptor ionotropic, NMDA 3B | 0 | 2 | 0 | 2 |
Glutamate receptor ionotropic, NMDA 3A | 0 | 2 | 0 | 2 |
mitogen-activated protein kinase 1 | 3 | 0 | 0 | 3 |
Potassium channel subfamily K member 3 | 0 | 1 | 0 | 1 |
Sodium channel protein type 1 subunit alpha | 0 | 1 | 0 | 1 |
Sodium channel protein type 2 subunit alpha | 0 | 1 | 0 | 1 |
Sodium channel protein type 3 subunit alpha | 0 | 1 | 0 | 1 |
Potassium voltage-gated channel subfamily A member 5 | 0 | 1 | 0 | 1 |
Potassium voltage-gated channel subfamily H member 2 | 0 | 6 | 0 | 6 |
Sodium channel protein type 5 subunit alpha | 0 | 2 | 0 | 2 |
Sodium channel protein type 9 subunit alpha | 0 | 1 | 0 | 1 |
Potassium voltage-gated channel subfamily D member 2 | 0 | 1 | 0 | 1 |
Potassium channel subfamily K member 18 | 0 | 1 | 0 | 1 |
Multidrug and toxin extrusion protein 1 | 0 | 2 | 0 | 2 |
Sodium channel protein type 3 subunit alpha | 0 | 2 | 0 | 2 |
Chain A, Ribulose-1,5 bisphosphate carboxylase/oxygenase large subunit N-methyltransferase, chloroplast | 0 | 1 | 0 | 1 |
Chain A, Ribulose-1,5 bisphosphate carboxylase/oxygenase large subunit N-methyltransferase, chloroplast | 0 | 1 | 0 | 1 |
Glutathione reductase, mitochondrial | 0 | 2 | 0 | 2 |
hypoxia-inducible factor 1, alpha subunit (basic helix-loop-helix transcription factor) | 5 | 0 | 0 | 5 |
PINK1 | 2 | 0 | 0 | 2 |
Glucocorticoid receptor | 0 | 6 | 2 | 8 |
Glycine receptor subunit alpha-1 | 0 | 6 | 0 | 6 |
Glycine receptor subunit beta | 0 | 6 | 0 | 6 |
Glycine receptor subunit alpha-2 | 0 | 6 | 0 | 6 |
Glycine receptor subunit alpha-3 | 0 | 6 | 0 | 6 |
Spike glycoprotein | 5 | 0 | 0 | 5 |
pregnane X receptor | 6 | 0 | 0 | 6 |
nonstructural protein 1 | 4 | 0 | 0 | 4 |
nuclear receptor subfamily 1, group I, member 2 | 1 | 0 | 0 | 1 |
transcriptional regulator ERG isoform 3 | 2 | 0 | 0 | 2 |
Estrogen receptor | 0 | 1 | 1 | 2 |
Sex hormone-binding globulin | 0 | 0 | 1 | 1 |
Progesterone receptor | 0 | 2 | 1 | 3 |
Mineralocorticoid receptor | 0 | 1 | 0 | 1 |
Androgen receptor | 0 | 2 | 2 | 4 |
Androgen receptor | 0 | 0 | 1 | 1 |
Histamine H2 receptor | 0 | 2 | 0 | 2 |
5-hydroxytryptamine receptor 1B | 0 | 3 | 0 | 3 |
Alpha-synuclein | 1 | 2 | 0 | 3 |
Aldo-keto reductase family 1 member C3 | 0 | 1 | 0 | 1 |
Aldo-keto reductase family 1 member C2 | 0 | 1 | 0 | 1 |
Guanine nucleotide-binding protein G | 2 | 0 | 0 | 2 |
Aldo-keto reductase family 1 member C1 | 0 | 1 | 0 | 1 |
Estrogen receptor beta | 0 | 1 | 1 | 2 |
Chain A, Putative fructose-1,6-bisphosphate aldolase | 1 | 0 | 0 | 1 |
Chain A, JmjC domain-containing histone demethylation protein 3A | 1 | 0 | 0 | 1 |
Fumarate hydratase | 1 | 0 | 0 | 1 |
apical membrane antigen 1, AMA1 | 1 | 0 | 0 | 1 |
polyprotein | 1 | 0 | 0 | 1 |
hemoglobin subunit beta | 1 | 0 | 0 | 1 |
urokinase-type plasminogen activator precursor | 1 | 0 | 0 | 1 |
plasminogen precursor | 1 | 0 | 0 | 1 |
urokinase plasminogen activator surface receptor precursor | 1 | 0 | 0 | 1 |
UDP-glucose 6-dehydrogenase | 0 | 1 | 0 | 1 |
Solute carrier family 22 member 8 | 0 | 0 | 0 | 1 |
Hypoxanthine-guanine phosphoribosyltransferase | 0 | 0 | 0 | 1 |
UDP-glucose 6-dehydrogenase | 0 | 1 | 0 | 1 |
Purine nucleoside phosphorylase | 0 | 0 | 1 | 1 |
UDP-glucuronosyltransferase 1A1 | 0 | 1 | 0 | 1 |
Solute carrier family 2, facilitated glucose transporter member 9 | 0 | 1 | 1 | 2 |
atrial natriuretic peptide receptor 2 precursor | 1 | 0 | 0 | 1 |
M-phase phosphoprotein 8 | 2 | 0 | 0 | 2 |
Sodium-dependent noradrenaline transporter | 0 | 1 | 0 | 1 |
Voltage-dependent L-type calcium channel subunit alpha-1F | 0 | 2 | 0 | 2 |
Aldo-keto reductase family 1 member B1 | 0 | 4 | 0 | 4 |
5-hydroxytryptamine receptor 1A | 0 | 1 | 1 | 2 |
Quinolone resistance protein NorA | 0 | 1 | 0 | 1 |
Angiotensin-converting enzyme | 0 | 2 | 0 | 2 |
Aldo-keto reductase family 1 member B1 | 0 | 1 | 0 | 1 |
Beta-adrenergic receptor kinase 1 | 0 | 1 | 0 | 1 |
Potassium voltage-gated channel subfamily A member 3 | 0 | 1 | 0 | 1 |
Sodium-dependent noradrenaline transporter | 0 | 4 | 1 | 5 |
Sodium-dependent dopamine transporter | 0 | 2 | 0 | 2 |
Beta-adrenergic receptor kinase 1 | 0 | 1 | 2 | 3 |
Substance-P receptor | 0 | 1 | 0 | 1 |
Rhodopsin kinase GRK1 | 0 | 1 | 0 | 1 |
Sodium-dependent serotonin transporter | 0 | 4 | 1 | 5 |
G protein-coupled receptor kinase 5 | 0 | 1 | 0 | 1 |
G protein-coupled receptor kinase 5 | 0 | 1 | 0 | 1 |
P2X purinoceptor 4 | 0 | 1 | 0 | 1 |
Voltage-dependent L-type calcium channel subunit alpha-1D | 0 | 2 | 0 | 2 |
Sodium-dependent dopamine transporter | 0 | 2 | 1 | 3 |
Envelope glycoprotein | 0 | 0 | 1 | 1 |
Voltage-dependent L-type calcium channel subunit alpha-1S | 0 | 2 | 0 | 2 |
Rhodopsin kinase GRK1 | 0 | 1 | 0 | 1 |
Sodium-dependent serotonin transporter | 0 | 1 | 0 | 1 |
Sodium-dependent dopamine transporter | 0 | 1 | 0 | 1 |
Nuclear receptor subfamily 3 group C member 3 | 0 | 2 | 0 | 2 |
P2X purinoceptor 4 | 0 | 1 | 0 | 1 |
Beta-adrenergic receptor kinase 1 | 0 | 0 | 0 | 1 |
Transporter | 0 | 2 | 0 | 2 |
Cytochrome P450 1A2 | 0 | 0 | 0 | 2 |
UDP-glucuronosyltransferase 2B7 | 0 | 1 | 0 | 1 |
UDP-glucuronosyltransferase 1-6 | 0 | 1 | 0 | 1 |
UDP-glucuronosyltransferase 1A1 | 0 | 1 | 0 | 1 |
UDP-glucuronosyltransferase 1A4 | 0 | 1 | 0 | 1 |
Arylacetamide deacetylase | 0 | 0 | 0 | 1 |
UDP-glucuronosyltransferase 2B10 | 0 | 1 | 0 | 1 |
Cytochrome P450 2J2 | 0 | 2 | 0 | 2 |
Solute carrier family 22 member 6 | 0 | 2 | 0 | 2 |
Arylacetamide deacetylase | 0 | 0 | 0 | 1 |
Arylacetamide deacetylase | 0 | 0 | 0 | 1 |
Sodium channel protein type 1 subunit alpha | 0 | 1 | 0 | 1 |
Sodium channel protein type 2 subunit alpha | 0 | 1 | 0 | 1 |
glp-1 receptor, partial | 3 | 0 | 0 | 3 |
beta-2 adrenergic receptor | 2 | 0 | 0 | 2 |
lysosomal alpha-glucosidase preproprotein | 1 | 0 | 0 | 1 |
mu-type opioid receptor isoform MOR-1 | 0 | 0 | 1 | 1 |
Vpr | 1 | 0 | 0 | 1 |
5-hydroxytryptamine receptor 2A | 0 | 0 | 1 | 1 |
dopamine D1 receptor | 1 | 0 | 0 | 1 |
Solute carrier family 22 member 1 | 0 | 2 | 0 | 2 |
Solute carrier family 22 member 2 | 0 | 2 | 0 | 3 |
Sterol O-acyltransferase 1 | 0 | 1 | 0 | 1 |
Solute carrier family 22 member 2 | 0 | 2 | 0 | 2 |
Solute carrier family 22 member 3 | 0 | 1 | 0 | 1 |
Acetylcholinesterase | 0 | 1 | 0 | 1 |
DNA (cytosine-5)-methyltransferase 1 | 0 | 1 | 0 | 1 |
Sterol O-acyltransferase 1 | 0 | 1 | 0 | 1 |
Solute carrier family 22 member 1 | 0 | 4 | 0 | 5 |
Solute carrier family 22 member 2 | 0 | 4 | 0 | 4 |
Solute carrier family 22 member 4 | 0 | 1 | 0 | 1 |
DNA (cytosine-5)-methyltransferase 3-like | 0 | 1 | 0 | 1 |
DNA (cytosine-5)-methyltransferase 3A | 0 | 1 | 0 | 1 |
heat shock 70kDa protein 5 (glucose-regulated protein, 78kDa) | 1 | 0 | 0 | 1 |
heat shock protein HSP 90-alpha isoform 2 | 0 | 0 | 0 | 1 |
Polyunsaturated fatty acid lipoxygenase ALOX15B | 1 | 0 | 0 | 1 |
heat shock protein 90, putative | 0 | 0 | 0 | 1 |
Chain A, Ferritin light chain | 0 | 0 | 1 | 1 |
Chain A, Ferritin light chain | 0 | 0 | 1 | 1 |
Chain A, Ferritin light chain | 0 | 0 | 1 | 1 |
Chain A, Ferritin light chain | 0 | 0 | 1 | 1 |
Chain A, Ferritin light chain | 0 | 0 | 1 | 1 |
Chain A, Ferritin light chain | 0 | 0 | 1 | 1 |
Chain A, Ferritin light chain | 0 | 0 | 1 | 1 |
caspase 7, apoptosis-related cysteine protease | 1 | 0 | 0 | 1 |
caspase-3 | 1 | 0 | 0 | 1 |
Fatty-acid amide hydrolase 1 | 0 | 1 | 0 | 1 |
UDP-glucuronosyltransferase 1A9 | 0 | 0 | 0 | 1 |
Polyunsaturated fatty acid lipoxygenase ALOX15 | 0 | 1 | 0 | 1 |
Sodium- and chloride-dependent GABA transporter 1 | 0 | 1 | 0 | 1 |
Sodium- and chloride-dependent GABA transporter 2 | 0 | 1 | 0 | 1 |
Sodium- and chloride-dependent GABA transporter 3 | 0 | 1 | 0 | 1 |
Sodium- and chloride-dependent betaine transporter | 0 | 1 | 0 | 1 |
UDP-glucuronosyltransferase 1A8 | 0 | 0 | 0 | 1 |
Beta-1 adrenergic receptor | 0 | 1 | 1 | 3 |
Voltage-dependent L-type calcium channel subunit alpha-1C | 0 | 1 | 0 | 1 |
Beta-2 adrenergic receptor | 0 | 2 | 3 | 5 |
Beta-1 adrenergic receptor | 0 | 2 | 2 | 4 |
Beta-2 adrenergic receptor | 0 | 2 | 0 | 3 |
Beta-3 adrenergic receptor | 0 | 2 | 2 | 4 |
D(2) dopamine receptor | 0 | 1 | 1 | 2 |
Beta-1 adrenergic receptor | 0 | 2 | 1 | 4 |
D(3) dopamine receptor | 0 | 1 | 0 | 1 |
D(1A) dopamine receptor | 0 | 1 | 1 | 2 |
Voltage-dependent L-type calcium channel subunit alpha-1C | 0 | 1 | 0 | 1 |
Beta-3 adrenergic receptor | 0 | 2 | 0 | 2 |
5-hydroxytryptamine receptor 1B | 0 | 2 | 1 | 3 |
5-hydroxytryptamine receptor 2A | 0 | 2 | 1 | 3 |
Neuromedin-K receptor | 0 | 0 | 1 | 1 |
Type-1 angiotensin II receptor | 0 | 1 | 1 | 2 |
Cholecystokinin receptor type A | 0 | 1 | 1 | 2 |
5-hydroxytryptamine receptor 7 | 0 | 1 | 1 | 2 |
Beta-1 adrenergic receptor | 0 | 1 | 0 | 1 |
Alpha-1A adrenergic receptor | 0 | 1 | 2 | 4 |
Alpha-1B adrenergic receptor | 0 | 0 | 1 | 2 |
Mu-type opioid receptor | 0 | 1 | 1 | 2 |
Vasopressin V1a receptor | 0 | 1 | 1 | 2 |
Delta-type opioid receptor | 0 | 1 | 1 | 2 |
Kappa-type opioid receptor | 0 | 1 | 1 | 2 |
5-hydroxytryptamine receptor 6 | 0 | 2 | 1 | 3 |
Beta-2 adrenergic receptor | 0 | 1 | 0 | 1 |
Sodium/bile acid cotransporter | 0 | 1 | 0 | 1 |
Beta-2 adrenergic receptor | 0 | 1 | 1 | 3 |
Nuclear receptor subfamily 2 group E member 1 | 0 | 0 | 2 | 2 |
Pyridoxal kinase | 0 | 0 | 0 | 1 |
Histidine-rich protein PFHRP-II | 0 | 1 | 0 | 1 |
Cytochrome P450 2D1 | 0 | 1 | 0 | 1 |
Cytochrome P450 2D26 | 0 | 1 | 0 | 1 |
Cytochrome P450 2D3 | 0 | 1 | 0 | 1 |
Solute carrier organic anion transporter family member 1A1 | 0 | 1 | 0 | 1 |
Cytochrome P450 2D4 | 0 | 1 | 0 | 1 |
Chain A, PLASMA RETINOL-BINDING PROTEIN PRECURSOR | 0 | 0 | 1 | 1 |
15-lipoxygenase, partial | 1 | 0 | 0 | 1 |
ubiquitin carboxyl-terminal hydrolase 2 isoform a | 1 | 0 | 0 | 1 |
Retinol-binding protein 4 | 0 | 0 | 1 | 1 |
Beta-lactoglobulin | 0 | 0 | 1 | 1 |
Amyloid-beta precursor protein | 0 | 2 | 0 | 2 |
Disintegrin and metalloproteinase domain-containing protein 17 | 1 | 0 | 0 | 1 |
Chain A, Lysr-type Regulatory Protein | 0 | 0 | 1 | 1 |
Chain A, Lysr-type Regulatory Protein | 0 | 0 | 1 | 1 |
Chain A, Lysr-type Regulatory Protein | 0 | 0 | 1 | 1 |
Chain A, 146aa long hypothetical transcriptional regulator | 0 | 0 | 1 | 1 |
Chain A, Anthranilate phosphoribosyltransferase | 0 | 1 | 0 | 1 |
Chain A, Anthranilate phosphoribosyltransferase | 0 | 1 | 0 | 1 |
Chain A, Anthranilate phosphoribosyltransferase | 0 | 1 | 0 | 1 |
Chain B, Anthranilate phosphoribosyltransferase | 0 | 1 | 0 | 1 |
Chain C, Anthranilate phosphoribosyltransferase | 0 | 1 | 0 | 1 |
Chain A, Anthranilate phosphoribosyltransferase | 0 | 1 | 0 | 1 |
Anthranilate phosphoribosyltransferase | 0 | 1 | 0 | 1 |
chaperonin-containing TCP-1 beta subunit homolog | 1 | 0 | 0 | 1 |
Estrogen receptor beta | 0 | 0 | 0 | 1 |
Inhibitor of nuclear factor kappa-B kinase subunit beta | 0 | 0 | 0 | 1 |
5'-AMP-activated protein kinase subunit beta-2 | 0 | 0 | 0 | 1 |
Polymerase acidic protein | 0 | 0 | 1 | 1 |
Stromelysin-1 | 0 | 0 | 1 | 1 |
Tyrosine-protein phosphatase YopH | 0 | 1 | 0 | 1 |
High mobility group protein B1 | 0 | 0 | 1 | 1 |
Aldo-keto reductase family 1 member B1 | 0 | 1 | 0 | 1 |
Prolyl 4-hydroxylase subunit alpha-1 | 0 | 1 | 0 | 1 |
Tyrosine-protein phosphatase non-receptor type 1 | 0 | 1 | 0 | 3 |
Estrogen receptor | 0 | 0 | 0 | 1 |
Cystathionine gamma-lyase | 0 | 1 | 0 | 1 |
5'-AMP-activated protein kinase subunit gamma-1 | 0 | 0 | 0 | 1 |
5'-AMP-activated protein kinase catalytic subunit alpha-2 | 0 | 0 | 0 | 1 |
Xanthine dehydrogenase/oxidase | 0 | 1 | 0 | 1 |
5'-AMP-activated protein kinase catalytic subunit alpha-1 | 0 | 0 | 0 | 1 |
Solute carrier family 22 member 7 | 0 | 0 | 0 | 1 |
Solute carrier family 22 member 8 | 0 | 1 | 0 | 1 |
Ubiquitin-like domain-containing CTD phosphatase 1 | 0 | 1 | 0 | 1 |
5'-AMP-activated protein kinase subunit gamma-3 | 0 | 0 | 0 | 1 |
5'-AMP-activated protein kinase subunit gamma-2 | 0 | 0 | 0 | 1 |
5'-AMP-activated protein kinase subunit beta-1 | 0 | 0 | 0 | 1 |
Protein-arginine deiminase type-4 | 0 | 2 | 0 | 2 |
Beta-2 adrenergic receptor | 0 | 0 | 1 | 3 |
Cereblon isoform 4 | 0 | 2 | 0 | 2 |
cAMP-specific 3',5'-cyclic phosphodiesterase 4B | 0 | 1 | 0 | 1 |
cAMP-specific 3',5'-cyclic phosphodiesterase 4C | 0 | 1 | 0 | 1 |
cAMP-specific 3',5'-cyclic phosphodiesterase 4D | 0 | 1 | 0 | 1 |
DNA-binding protein Ikaros | 0 | 0 | 0 | 1 |
DNA damage-binding protein 1 | 0 | 1 | 1 | 2 |
Protein cereblon | 0 | 4 | 1 | 6 |
Chain A, Nuclear Receptor ROR-beta | 0 | 1 | 0 | 1 |
thyrotropin-releasing hormone receptor | 1 | 0 | 0 | 1 |
Ornithine decarboxylase | 0 | 0 | 0 | 1 |
60 kDa chaperonin | 0 | 1 | 0 | 1 |
Retinoic acid receptor alpha | 0 | 2 | 2 | 7 |
60 kDa heat shock protein, mitochondrial | 0 | 1 | 0 | 1 |
Retinoic acid receptor beta | 0 | 2 | 2 | 7 |
Retinoic acid receptor gamma | 0 | 2 | 2 | 7 |
Retinoic acid receptor RXR-alpha | 0 | 2 | 2 | 4 |
Retinoic acid receptor RXR-beta | 0 | 2 | 2 | 4 |
Indoleamine 2,3-dioxygenase 1 | 0 | 1 | 0 | 1 |
Nuclear receptor ROR-alpha | 0 | 1 | 0 | 1 |
Retinoic acid receptor RXR-gamma | 0 | 2 | 2 | 4 |
10 kDa heat shock protein, mitochondrial | 0 | 1 | 0 | 1 |
Peptidyl-prolyl cis-trans isomerase NIMA-interacting 1 | 0 | 2 | 1 | 3 |
Thiosulfate sulfurtransferase | 0 | 1 | 0 | 1 |
60 kDa chaperonin | 0 | 1 | 0 | 1 |
10 kDa chaperonin | 0 | 1 | 0 | 1 |
Indoleamine 2,3-dioxygenase 2 | 0 | 1 | 0 | 1 |
Nuclear receptor ROR-beta | 0 | 1 | 0 | 1 |
Chain A, Cytidine Deaminase | 0 | 1 | 0 | 1 |
Sodium/nucleoside cotransporter 1 | 0 | 2 | 0 | 2 |
Sodium/nucleoside cotransporter 2 | 0 | 2 | 0 | 2 |
Cytidine deaminase | 0 | 1 | 0 | 1 |
Equilibrative nucleoside transporter 2 | 0 | 2 | 0 | 2 |
Equilibrative nucleoside transporter 1 | 0 | 2 | 0 | 2 |
Uridine-cytidine kinase 1 | 0 | 0 | 0 | 1 |
Solute carrier family 28 member 3 | 0 | 2 | 0 | 2 |
Chain A, Arginase 1 | 0 | 1 | 0 | 1 |
Large neutral amino acids transporter small subunit 1 | 0 | 1 | 0 | 1 |
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023] |